Loading...

HEREDITARY CANCER DELETION & DUPLICATION ANALYSIS (30 GENES), EDTA WHOLE BLOOD

image not found

NABL Cap Accredited 
The Hereditary Cancer Deletion & Duplication Analysis (30 Genes), EDTA Whole Blood is a specialized genetic test that detects large gene deletions or duplications linked to inherited cancer syndromes. Using advanced NGS-based copy number analysis, Metropolis Healthcare identifies structural gene variations that may increase cancer risk. This test supports early detection, preventive strategies, and personalized surveillance plans. It is especially useful when point-mutation testing is inconclusive but hereditary risk is still suspected. 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 14,000.00

Sample Type: EDTA WHOLE BLOOD

Fasting Not Required


Notes:H5805

Frequently Asked Questions (FAQ's):

What does this hereditary cancer test include?
It analyzes 30 key cancer-related genes to detect large deletions or duplications using advanced genomic methods at Metropolis Healthcare.

How does Metropolis Healthcare perform this analysis?
The lab uses high-resolution NGS copy number assessment with strict quality controls to identify clinically significant structural variants.

Who should consider taking this test?
Individuals with a strong family history of cancers like breast, ovarian, colorectal, or prostate cancer may benefit from this analysis.

Why is deletion and duplication testing important?
Some hereditary cancer risks come from large gene changes not detectable by routine sequencing, making this test essential for thorough evaluation.

What sample is required for this test?
An EDTA whole blood sample is needed to extract high-quality DNA for analysis.

How long does Metropolis Healthcare take to release results?
Results are generally available within a few weeks, depending on panel complexity.

Can this test help with preventive planning?
Yes, identifying pathogenic variants helps clinicians plan early screening, preventive measures, and risk-reduction strategies.

Is this test useful for family screening?

Absolutely—once a significant variant is detected, targeted testing can be offered to family members for risk assessment 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab